Assessment of Antihypertensives Drug Class in Type 2 Diabetes and It’s Complications


Assessment of Antihypertensives Drug Class in Type 2 Diabetes and It’s Complications


Margreth Philbert, Binai K Sankar

Reddy college of pharmacy


 International Journal of Hospital Pharmacy

Background: Hypertension and Diabetes are now serious public and worldwide health challenge as by 2025 it has been estimated that 1.56 billion world population will suffer from hypertension and diabetes is the 8th leading cause of death.
Objectives:Primary objective is assessment of antihypertensive drug classes used in type 2 diabetes & it’s complications and Secondary objectives are , is to assess the prescribing pattern of diabetic drugs, and to assess the incidence of complications in diabetes mellitus.
Methods & Materials: This was a prospective observational study carried out at Dr. B.R. Ambedkar Medical College and Hospital. Data collection form was prepared and study was carried out in Patients with inclusion criterias after they were briefed about the study and oral consent was obtained from them.
Results: 150 patients were included in the study, with females 66.67%. The average age of patients included in the study was 57.97±9.90, belonging to the age group 55-64 years. Out of 150 patients 105 had diabetic complications. Patients with Diabetic Nephropathy CCB 38.71% and the combination of ARB with diuretic 22.58% were prescribed, In patients with cardiovascular diseases they were mostly prescribed with CCB 34.29% followed by Beta-Blockers 20.00%, in patients with cerebrovascular diseases combinations of ARB with Diuretic 30.77% were most prescribed and in diabetic foot CCB 45.83% were prescribed. Managing diabetes, Metformin was the most prescribed as mono-therapy in 24.49% patients and as the combination with Glimepiride was used in 56.46% patients.
Conclusion: This study revealed that CCB as monotherapy and ARB with diuretics as dual therapy were the most commonly used agents with diabetic complications like diabetic neuropathy, cardiovascular diseases and diabetic foot. A larger sample size may be necessary to reach a conclusion on the benefits of particular classes of drug in different diabetes complication so as to slower their progression.


Free Full-text PDF


How to cite this article:
Margreth Philbert, Binai K Sankar. Assessment of Antihypertensives Drug Class in Type 2 Diabetes and It’s Complications. International Journal of Hospital Pharmacy, 2018,3:12.


References:

1. Diabetes Mellitus [Internet]. New York: Wikipedia Foundation; c2016 [updated 2016 Dec; Cited 2016 Dec 20]. Available from: https://en.wikipedia.org/wiki/Diabetes_mellitus
2. MacLaughlin EJ, Saseen JJ. Hypertension. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy; a pathophysiological Approach. 7th Ed. New York: McGraw Hill Companies; 2008. P.139-172.
3. Diabetes and high blood pressure. Boots Webmed Medical References. [updated 2012 Feb; Cited 2016 Dec 20]. Available from: http://www.webmd.boots.com/diabetes/guide/diabetes-bp
4. Why do so many people with diabetes also have high blood pressure [Internet]. New York:Liberty medical. c2016[updated 2010 May 11; Cited 2016 Dec 20]. Available from: http://libertymedical.com/ diabetes/why-do-so-many-people-with-diabetes-also-have-high-blood-pressure
5. Diabetes and high blood pressure [Internet] London:Blood Pressure Association; 2008 [Updated 2008 ; cited 2017 March 27]. Available from: http://www.bloodpressureuk.org/BloodPressureandyou/Yourbody/Diabetes
6. Diabetes and High Blood Pressure; How to Manage Both [Internet]. Everyday Health Media; 2017 [Updated 2008 ; cited 2017 March 27]. Available from: http://www.everydayhealth.com/hs/type-2-diabetes/diabetes-and-high-blood-pressure
7. High Blood Pressure and Diabetic Kidney Disease [Internet]. United States: Joslin Diabetes Center; 2017 [Updated 2008 ; cited 2017 March 27]. Available from: http://www.joslin.org/info/High-Blood-Pressure-and-Diabetic-Kidney-Disease.html
8. Overview of Diabetic Kidney Disease [Internet]. Joslin:Joslin Diabetes Center,Inc.;2017 [Updated 2017 Feb ; cited 2017 March 27]. Available from: http://www.joslin.org/info/diabetic-kidney-disease.html
9. Elke J, Thomas O, Horst CV, Matthias K, Angelica B, Claudia MW. Evaluation of prescribing patterns in a German network of CAM physicians for the treatment of patients with hypertension: a prospective observational study. Fam Prac [Internet]. 2009 Dec [cited 2017 March 27]; 10(78):1471-2296. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2804584
10. Shah J, Khakhkhar T, Bhirud S, Shah RB, Date S. Study of utilization pattern of anti-hypertensive drugs in hypertensive diabetic patients with or without reduced renal function at tertiary care teaching hospital. Int J Med Sci Pub Health [ Internet]. 2013 Jan [Cited 2017 Feb 20]; 2(2):175-180. Available from: www.ejmanager.com/mnstemps/67/67-1354178702
11. Sepulveda E, Poinhos R, Constante M, Pairs-Ribeiro J, Freitas P, Carvalho D. Relationship between chronic complications, hypertension and health related quality of life in patients in type 2 diabetes. Diabetes Metab Synder Obes [Internet]. 2015 Oct [cited 2016 Dec 12]; 8: [535-42]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26586958
12. Jangan T, Kavitha R, Sridevi S.A, Veerendra V. Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital. Int J Pharm Res Review [Internet]. 2014 Jan [Cited 2016 Dec 20]; 3(1):1-5. Available from: https://www.ijpr.in/Data/Archives/2014/january/0412201301.pdf
13. Dhanaraj E, Raval A, Yadav R,Bhansali A, Tiwari P. Prescription Pattern of Antihypertensive Agents in T2DM Patients Visiting Tertiary Care Centre in North India. Int J Hypertension [Internet]. 2012 Aug [Cited 2016 Dec 20]; 2012(9). Available from: https://www.hindawi.com/journals/ijhy/2012/520915.
14. Boccuzzi S J, Wogen, Wogen J, Fox J, Sung JCY, Shag AB, Kim J. Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. Population. Diabetic Care [Internet]. 2001 Jan. [Cited 2016 Dec 20];24(8):1411–1415. Available from:care.diabetesjournals.org/content/diacare/24/8/1411.